Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V9DQ
|
|||
| Former ID |
DNC005643
|
|||
| Drug Name |
[3-(5-Phenyl-oxazol-2-ylamino)-phenyl]-methanol
|
|||
| Synonyms |
3-(5-phenyl-oxazol-2-ylamino)phenylmethanol; 681002-56-2; [3-[(5-phenyl-1,3-oxazol-2-yl)amino]phenyl]methanol; {3-[(5-phenyl-1,3-oxazol-2-yl)amino]phenyl}methanol; 2-Anilino-5-aryloxazole 12; AC1NS7RB; CHEMBL194113; BDBM5851; SCHEMBL5185668; ZINC13611262; KB-305372; N-(3-Hydroxymethylphenyl)-5-phenyl-1,3-oxazol-2-amine Hydrochloride
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H14N2O2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CN=C(O2)NC3=CC=CC(=C3)CO
|
|||
| InChI |
1S/C16H14N2O2/c19-11-12-5-4-8-14(9-12)18-16-17-10-15(20-16)13-6-2-1-3-7-13/h1-10,19H,11H2,(H,17,18)
|
|||
| InChIKey |
WTSNQZLKTLSHSD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors. J Med Chem. 2005 Mar 10;48(5):1610-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.